Cyber Creation Ventures (CCV) and the Institute of AI for Science, Peking University Shenzhen Graduate School (Institute of AI4Sci, PKU), have launched the Cybernova Accelerator, a platform to accelerate the commercialization of AI-driven scientific research, bridging academic breakthroughs with real-world applications.
Cybernova Accelerator launched to commercialize AI-driven research.
Partnership between CCV and Institute of AI4Sci, PKU, announced September 2, 2025.
Focuses on rigorous validation, commercial empowerment, and market acceleration.
Hosts events like Cybernova Demo Day and AI Research Industrialization Summit.
CCV brings $2B in assets and a 35% unicorn formation rate.
AI4Sci, PKU, excels in drug discovery, protein modeling, and generative AI.
The Cybernova Accelerator, launched on September 2, 2025, in Singapore, aims to close the gap between academic AI research and market applications. The Institute of AI4Sci, PKU, provides world-class research in fields like drug discovery, protein modeling, and generative AI, while CCV contributes expertise in commercialization and access to global capital networks. “This partnership integrates academic discovery with entrepreneurial acceleration to scale AI projects with transformative impact,” said a CCV spokesperson.
The accelerator employs a three-pronged approach:
Rigorous Technology Validation: Led by AI4Sci, PKU, ensuring breakthroughs meet academic and technical standards.
Commercial Empowerment: CCV drives market validation, business model design, and financing connections.
End-to-End Market Acceleration: Both parties facilitate industrial deployment and global events to fast-track adoption.
Cybernova fosters an open ecosystem, uniting academic mentors, industry leaders, and investors. Selected projects receive mentorship, technical guidance, and market entry strategies.
Cybernova will host the annual Cybernova Demo Day and AI Research Industrialization Summit, alongside regular roadshows and matchmaking events, to showcase innovations and foster collaborations. These initiatives aim to accelerate the journey from lab to market, positioning Cybernova as a global leader in AI commercialization.
Founded by Wei Zhou, former Managing Partner of KPCB China, CCV is a global venture capital firm with nearly $2 billion in assets under management. Operating across Singapore, Silicon Valley, and Beijing, CCV boasts a 35% unicorn formation rate, with investments in companies like JD.com (NASDAQ:JD) and Perfect Corp (NYSE:PERF). Its partners are recognized among Forbes’ Top 100 Most Influential Global Chinese and Fortune’s Top 30 Investors.
The Institute of AI4Sci, PKU, established to support China’s Greater Bay Area innovation ecosystem, focuses on AI for Science, large language models, and algorithm-chip co-design. Equipped with the “Peng Cheng Cloud Brain” supercomputing cluster, it supports startups in overcoming technical challenges, driving commercialization of cutting-edge AI innovations.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.